Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46596
Title: | Investigation of blood leptin and adropin levels in patients with multiple sclerosis A CONSORT-clinical study | Authors: | Cinkir, Ufuk Bir, Levent Sinan Topsakal, Senay Cicek, Esin Avci Tekin, Selma |
Keywords: | adipokine biomarker inflammation mammalian target of rapamycin neurodegeneration Huntingtons-Disease Akt Prevalence Activation Pathway Mtor Survival Akt/Pkb Kinase Cells |
Publisher: | Lippincott Williams & Wilkins | Abstract: | Background: The effects of adipokines have been investigated in multiple sclerosis (MS) in the literature. Results are uncertain, and subgroups like adropin have not been previously studied. We primarily aimed to determine leptin and adropin levels in MS and their potential use as a biomarker. Methods: This study was an experimental research. While 44 MS patients diagnosed according to McDonald criteria were included in the patient group, 40 people without MS diagnosis and risk factors took part in the control group. Demographic data, height, weight, body mass index, blood glucose, thyroid-stimulating hormone, alanine transaminase, aspartate transaminase, creatinine, low-density lipoprotein, leptin, adropin levels, presence of hypertension, diabetes mellitus, coronary artery disease were recorded. Expanded disability status scale and disease duration were also evaluated in the patient group. Our data were presented as mean +/- standard deviations. Results: The mean blood leptin value of the patient group (6.12 +/- 5.34 ng/mL) was significantly lower than the value of the control group (13.02 +/- 8.25 ng/mL) (P < .001). The patient group had a mean adropin level of 504.12 +/- 311.17 ng/mL, which was significantly lower than that of the control group (747.0 +/- 309.42 ng/mL) (P < .001). Statistically insignificant differences were found between their body mass index, glucose, alanine transaminase, aspartate transaminase, thyroid-stimulating hormone, low-density lipoprotein levels (P > .001). Conclusion: This is the first study that has evaluated adropin levels in patients with MS. The relationship between MS and leptin levels is still unclear. Therefore, our study might be helpful to elucidate MS pathogenesis and provide supportive criteria for diagnosis. | URI: | https://doi.org/10.1097/MD.0000000000027247 https://hdl.handle.net/11499/46596 |
ISSN: | 0025-7974 1536-5964 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
investigation_of_blood_leptin_and_adropin_levels.45.pdf | 217.13 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
2
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
3
checked on Nov 21, 2024
Page view(s)
66
checked on Aug 24, 2024
Download(s)
32
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.